Abstract
Exosomes are nano-vesicles secreted by tumor cells. Exosomes can transfer complex biological information and induce a diverse signaling response in a wide array of pathological conditions, such as hypoxia. Hypoxia is associated with aggressive phenotypes and poor outcomes in nasopharyngeal carcinoma (NPC) patients. Here, we analyzed the role of exosomes from hypoxic NPC cells in enhancing the metastases of normoxic cells in a hypoxia-induced factor-1α (HIF-1α)-dependent manner. HIF-1α rapidly accumulates and trans-activates hundreds of genes, such as matrix metalloproteinases (MMPs). We found that MMP-13 was over-expressed in exosomes and cells under hypoxic conditions. HIF-1α depletion in hypoxic CNE2 cells led to decreased MMP-13 levels in exosomes and significantly reduced cell migration and invasion. Moreover, exosomal MMP-13 significantly up-regulated Vimentin expression while decreasing E-cadherin levels in CNE2 cells in vitro and in vivo. Furthermore, MMP-13 levels were closely associated with HIF-1α expression (r = 0.679, P < 0.001), lymph node metastasis, clinical stage (all P < 0.05) and poor prognosis in NPC patients (P < 0.01). In conclusion, our findings suggest that the hypoxic exosomes were loaded with MMP-13, which could enhance migration and invasiveness and induce microenvironment changes to promote NPC aggressiveness.
Similar content being viewed by others
Introduction
Nasopharyngeal carcinoma (NPC) is a squamous epithelial cancer arising from the lateral wall surface of the nasopharynx1,2, and it has the highest metastatic potential among head and neck cancers. Distant metastasis is the major cause of treatment failure3. At the time of diagnosis, 74.5% of NPC patients present with regional lymph node metastasis, and 19.9% present with distant metastasis3. Post-treatment local relapse and particularly distant metastasis remain the major problematic issues that eventually lead to the death of patients with advanced NPC4. Further research of the molecular mechanisms of NPC tumorigenesis is urgently needed, especially regarding metastases, to improve the prognosis of patients.
It has become generally accepted that cancer progression is driven by hypoxic signaling, and the expression of hypoxia-related markers has been correlated with poor patient outcome in several tumor types, which could partly relate to tumor metastases5. Hypoxia is recognized as the most common features of the tumor microenvironment that contributes to tumor progression by activating adaptive transcriptional programs, thereby promoting tumor cell survival, motility, metastases and angiogenesis6,7,8. Clinical studies showed that 100% of primary NPC and 58% of cervical nodal metastases of NPC were found to contain hypoxic regions with over-expression of hypoxia-inducible factor-1α (HIF-1α) which is associated with an increased risk of metastases and patient mortality4. HIF-1α has become a prognostic factor as well as a potential therapeutic target of NPC9. HIF-1α can accumulate and rapidly trans-activate hundreds of target genes under hypoxia, such as angiogenic and proliferating factors, glucose transporters10 as well as matrix metalloproteinases (MMPs)11. MMP-13, a member of the MMP family, is often over-expressed in various tumors12,13,14,15,16, and it has been documented to increase the risk of metastases of cancers of the head and neck14 and melanoma17. The recent discovery of exosomes and their extracellular presence suggest a potential role of these regulatory molecules in defining the metastatic potential of cancer cells and mediating the microenvironment16. In previous work, we proved that exosomes from NPC containing MMP-13 which could mediate the tumor microenvironment, such as by facilitating tumor cell migration and invasion by inducing epithelial–mesenchymal transition (EMT)18.
Exosomes are nano-sized (50–100 nm in diameter) membrane-bound vesicles released by a variety of cell types, especially abundantly by tumor cells19. Recent evidence has highlighted a role for hypoxic tumor cell-derived exosomes in promoting tumor progression20. Exosomes may participate in intercellular signaling, e.g., via protein ligands in the exosome membrane that activate signaling receptors and downstream kinases, and through the transfer of protein, microRNAs (miRNAs), messenger RNAs (mRNAs) and signaling receptors to recipient cells5. Kucharzewska et al.5 found that exosomes constitute a potentially targetable mediator of hypoxia-driven tumor development and that the exosomal molecular signature could serve as a noninvasive biomarker to assess the oxygenation status and aggressiveness of malignant tumors. Given the observations that independently link the hypoxia microenvironment and exosome-mediated signals to invasive tumor phenotypes, it is of great interest to investigate whether hypoxia could promote tumor progression through altered exosomes release.
In the present study, we further investigated whether NPC cells exposed to hypoxia release exosomes containing a higher level of MMP-13 in an HIF-1α-dependent manner, therefore enhancing metastases by inducing EMT in vitro and in vivo. We found that over-expression of HIF-1α and MMP-13 could be involved in the carcinogenesis and development of NPC and that their over-expression was associated with patients’ poor prognosis. Taken together, MMP-13 over-expression was triggered by hypoxia/HIF-1α as an important mechanism to induced EMT and tumor invasion in NPC.
Results
Hypoxic nasopharyngeal cancer cell-derived exosomes induced metastases of normoxic cells
In previous work, we proved that MMP-13-containing exosomes from NPC could mediate the tumor microenvironment by facilitating tumor cell migration and invasion via the induction of EMT18. As hypoxia facilitates metastasis-associated processes, including the EMT, invasive migration and angiogenesis, it is of interest to investigate whether NPC cells could enhance the invasiveness and motility of naive NPC cells under hypoxic conditions by transferring information packaged in exosomes.
We incubated NPC cells under hypoxic conditions, and found that HIF-1α increased with a time dependency under oxygen deprivation conditions (Supplementary Figure 1a-f). We also observed morphological, protein and mRNA changes of EMT as well as the enhanced tumor migration in CNE2 cell lines under hypoxia (Supplementary Figure 2a-e). Exosomes were purified from the conditioned medium (CM) of normoxic and hypoxic CNE2 cells. Electron microscopy and immunoblot analysis confirmed the presence of exosomes (Fig. 1a, b). There was no significant difference between the morphology of exosomes under hypoxic conditions compared to the normal conditions.
Once secreted, exosomes deliver biologic information that is internalized by neighboring or distant cells. We sought to investigate whether exosomes derived from hypoxic tumor cells could affect normoxic cells. PKH67-labeled exosomes were incubated with normoxic CNE2 cells for 1 h. The recipient cells exhibited a high uptake efficiency, as indicated by fluorescence microscopy (Fig. 1c) and flow cytometry (Fig. 1d), without a significant difference between normoxic and hypoxic cell- derived exosomes (Fig. 1d). However, after 1 h of incubation with labeled exosomes, >90% of the recipient cells were positive for PKH67 fluorescence (Fig. 1c). Transwell assays showed that hypoxic exosomes could facilitate the metastasis capacity of normoxic CNE2 cells compared with normoxic exosomes (Fig. 1e, f). Recent studies show that zebrafish represents a promising alternative model in cancer research21,22. In these studies, Dil-labeled CNE2 cells mixed with the same amount of normoxic or hypoxic exosomes were injected at the blastula stage to explore the potential effect of exosomes in cancer metastases. At day 8 after implantation, CNE2 cells with hypoxic exosomes were significantly disseminated away from primary sites (Fig. 1g, h) compared with CNE2 cell with normoxic exosomes. These results suggested that hypoxic exosomes facilitated the metastasis of nasopharyngeal cancer cells.
Hypoxia stimulates exosomal MMP-13 expression in HIF-1α-dependent manner
Exosomes have been demonstrated to contain protein and miRNAs, which can be delivered to other cells and affect cellular function20. Our previous study showed that exosomes purified from the NPC patients’ peripheral plasma contained MMP-13 and promoted NPC metastasis. Hypoxia has been reported to enhance MMP activity; however, MMP activity in hypoxic NPC exosomes has not been studied. After oxygen deprivation for 24 h, the level of MMP-13 was up-regulated in hypoxic exosomes compared with exosomes purified under normal conditions (Fig. 2a, b) as well as in cells (Supplementary Figure 3a-c). Consistent with previous studies, the level of HIF-1α mRNA was unchanged even under hypoxic conditions, while the expression of MMP-13 was up-regulated (Supplementary Figure 3c). To further study whether hypoxia-induced MMP-13 expression was HIF-1α dependent, CNE2 cells were treated with the most effective HIF-1α-target small interfering RNA (siRNA; Supplementary Figure 3d). In normoxic conditions, cellular and exosomal MMP-13 levels were not significantly affected by HIF-1α knockdown (Supplementary Figure 3f-h). However, in hypoxic conditions, cellular (Supplementary Figure3i-l) and exosomal (Fig. 2c, d) MMP-13 levels were decreased by HIF-1α knockdown. These results suggested that hypoxia-induced cellular and exosomal MMP-13 expression is dependent on HIF-1α in CNE2 cells. To determine whether MMP-13 was a direct HIF-1α target gene, we analyzed the MMP-13 locus for the presence of consensus HIF binding site sequences (Fig. 2e). Chromatin immunoprecipitation (ChIP) assays were used to further validate the binding of HIF-1α to the predicted hypoxia-responsive element (HRE) region of MMP-13. PCR products corresponding to the MMP-13 HRE-containing promoter region were detected in cells cultured in 1% O2 after HIF-1α immunoprecipitation (Fig. 2f). These results confirmed the direct binding of HIF-1α to MMP-13 upon exposure to hypoxia.
MMP-13 mediated hypoxic exosome-induced cell migration and invasion
Our previous study showed that NPC exosomes that were taken up by receipt cells in the tumor microenvironment resulted in higher EMT and angiogenesis18. To study the function of exosomal MMP-13, we treated hypoxic CNE2 cells with MMP-13 targeted siRNA (Fig. 2g, i), and siRNA-1 was selected for subsequent trials. CNE2 cells were treated with hypoxic exosomes derived from MMP-13 knockdown cells. As shown in Fig. 2h, j, the knockdown of MMP-13 exosomes significantly decreased the migration (upper) and invasion (lower) of target cells compared with hypoxic exosomes. Moreover, exosomal MMP-13 markedly decreased the E-cadherin level, which acts as an epithelial cell marker, while the level of the mesenchymal marker Vimentin was up-regulated (Fig. 2k, o, p) in exosome-treated cells. Various transcription factors such as Twist, Snail, Slug, ZEB1 and ZEB2 are known to orchestrate EMT by activating the crosstalk of signaling networks that confer traits of self-renewal and invasiveness to cancer cells. We further explored whether other factors in exosomes involved in EMT were aberrantly expressed under hypoxic conditions. As shown in Supplementary Figure 4, there was no significant difference in the expression of Slug and Snail in exosomes. The data showed that hypoxic exosome-induced cell migration and invasion was dependent on MMP-13 by mediating the progression of EMT of the target cells. Further study showed that hypoxic exosomes were taken up by receipt human umbilical vein endothelial cells (HUVECs; Supplementary Figure 5c), which facilitated the proliferation (Supplementary Figure 5a) and tube formation (Supplementary Figure 5e) of HUVECs. MMP-13 knockdown decreased the exosomal properties mentioned above (Supplementary Figure 5b, d, and e).
Tumor growth was diminished by exosomes from MMP-13 knockdown cells
To further confirm the effect of MMP-13, we performed an in vivo tumorigenesis experiment in nude mice. Tumor volumes and growth rates were significantly decreased in tumors derived from shMMP-13-treated CNE2 cells (Fig. 3a, b) (Supplementary Figure 6). As shown in Supplementary Figure 6, the expression of MMP-13 was reduced by MMP-13 small hairpin RNA (shRNA). These tumors also exhibited a reduction in MMP-13 expression by immunohistochemistry but unchanged HIF-1α expression (Supplementary Figure 7). Consistent with these results, MMP-13 exerted a significant inhibitory effect on tumor genesis in vivo.
Furthermore, to investigate the role of tumor-derived exosomal MMP-13 in tumor growth and metastasis, normoxic and hypoxic exosomes purified from MMP-13 shRNA-treated cells (200 μg/ml) were then injected into the xenograft tumors. The hypoxic exosomes increased the growth of the tumor. MMP-13 knockdown reversed the promotion of tumor growth by hypoxic exosomes (Fig. 3a, c). MMP-13 expression decreased in CNE2 tumors treated with shMMP-13 exosomes (Fig. 3d, e). We next investigated whether exosomal MMP-13 regulates EMT in vivo. Consistent with the in vitro experiments, hypoxic exosomes and MMP-13 knockdown exosome-treated tumors had decreased expression of E-cadherin as well as markedly induced the expression of Vimentin (Fig. 3f).
These data indicated that the hypoxic microenvironment could stimulate tumor cells to produce exosomes that carry greater amounts of MMP-13. These MMP-13-rich exosomes would then potentially induce non-hypoxic cells to invade and metastasize.
HIF-1α and MMP-13 were over-expressed and associated with invasion and metastases in NPC tissues
As our previous work confirmed that MMP-13 was over-expressed in exosomes purified from NPC patients, further work was done to analyze the correlation between MMP-13, HIF-1α and clinical–pathologic parameters. Western blot showed that in the fresh NPC tissues, HIF-1α and MMP-13 were over-expressed compared to normal tissue samples (Fig. 4a, b). To gain further insight into the prognostic value of HIF-1α and MMP-13 expression in patients with NPC, paraffin-embedded tissue sections (n = 126) were examined using immunohistochemistry (Fig. 4c). High HIF-1α expression was localized to the nuclei and cytoplasm in 69.05% (87/126) of the resected tumor tissue samples. MMP-13-positive staining was observed in the cytoplasm of NPC cells in 67.46% (85/129) of the NPC samples. No positive expression of HIF-1α was detected in 30 normal control samples, which was in accordance with the previous study24. A total of 23.3% (7/30) of sections had MMP-13-positive expression. The positive rates of HIF-1α and MMP-13 expressions in NPC were significantly higher than those in the normal controls (P < 0.05). These results above suggested that high levels of HIF-1α and MMP-13 could be potential detections or prognostics biomarkers for NPC.
Relationship between HIF-1α and MMP-13 protein expression and clinicopathological features that predict poor prognosis
Spearman's analysis further revealed that HIF-1α expression was positively correlated with MMP-13 expression (r = 0.679, P < 0.01) in NPC (Fig. 4d). Immunohistochemical determination of HIF-1α and MMP-13 levels was also statistically analyzed to identify their association with the clinicopathologic features of NPC. HIF-1α expression was significantly correlated with lymph node stage (P = 0.031) and clinical stage (P = 0.001), but there was no significant association with gender, age and T stage (all P > 0.05). Moreover, high MMP-13 expression was significantly associated with T classification (P = 0.043), lymph node metastasis (P = 0.008) and clinical stage (P < 0.01) of patients with NPC. There was no relationship between MMP-13 expressions and age or gender (all P > 0.05) (Table 1). The determination of the prognosis of the NPC patients with HIF-1α expression level was also investigated in our work. Prior to the date of the last follow-up, our data showed that overall survival time was shorter in the HIF-1α-positive group compared with the HIF-1α-negative group (P < 0.01). The same result was shown in MMP-13-positive cases (P < 0.01). Kaplan–Meier survival curves also showed that patients with both HIF-1α- and MMP-13-positive expressions were associated with poorer overall survival than those with both HIF-1α- and MMP-13-negative expressions (P < 0.01) (Fig. 4e–g). Univariate analyses showed that T classification (P = 0.034), lymph node metastases (P < 0.01), clinical stage (P < 0.01), HIF-1α expression (P < 0.01) and MMP-13 expression (P < 0.01) were all significantly correlated with patients’ survival (Table 2). These data suggest that HIF-1α is correlated with MMP-13 expression in NPC samples and can predict poor prognosis of NPC patients before treatment.
In summary, our data offer convincing evidence that the hypoxic microenvironment stimulates NPC cells to produce exosomes containing greater amounts of MMP-13. These MMP-13-rich exosomes could participate in the progression of EMT to convert normoxic cells to a malignant phenotype.
Discussion
NPC is a highly invasive malignancy with early cervical lymph node metastases at the time of diagnosis. Hypoxia is an important element of the tumor microenvironment25,26, and is associated with aggressive tumor phenotypes and poor patient outcomes27. A previous study showed that all primary NPC tissues contain hypoxic regions which were associated with increased distant metastases, decreased local control and resistance to chemotherapy in advanced NPC patients4. HIF-1α is a central component of hypoxia that binds to hypoxic-responsive elements and up-regulates hypoxic-regulated genes, inducing changes that enable tumor cells to survive apoptosis, angiogenesis and metastases28. Furthermore, under hypoxic conditions, HIF-1α rapidly accumulates and trans-activates hundreds of genes, such as MMPs29. In our study, we found that HIF-1α and MMP-13 were over-expressed in NPC tissues. To gain further insight into the prognostic value of the biologic and clinicopathologic significance of HIF-1α and MMP-13 in NPC, immunohistochemical staining analysis showed that MMP-13 and HIF-1α over-expression were correlated with the lymph node metastases, clinical stage and poor prognosis of patients with NPC (P < 0.05), but not with age, gender and T stage. HIF-1α expression was positively correlated with MMP-13 (r = 0.679, P < 0.001). These data suggested MMP-13 had an oncogenic role in NPC as well as HIF-1α.
Exosomes are nano-sized (50–100 nm in diameter) membrane-bound vesicles that contain a wide range of functional proteins, mRNAs, and miRNAs30. Ohyashiki et al. had demonstrated that exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-123. In our study, the results of transwell and zebrafish tumor models showed that hypoxic NPC cell-derived exosomes enhanced the invasiveness and motility of naive NPC cells.
MMPs are a group of zinc-dependent proteolytic enzymes that stimulate tumorigenesis and establish metastatic foci at the secondary sites27. MMP-13 is an important type of MMPs that is often over-expressed in various tumors and participates in tumor metastases. We provided evidence that hypoxia increased the MMP-13 levels in tumor-derived exosomes in a HIF-1α-dependent manner. ChIP assay was further used to confirm that MMP-13 was a direct HIF-1α target gene.
Previously, HIF-1α, a major mediator of hypoxia, has been reported in some malignant tumors to promote EMT24,31,32. Our data showed that under oxygen deprivation conditions or treatment with CoCl2, HIF-1α was up-regulated in NPC cells, and the level increased more in the poorly differentiated CNE2 cells compared to the well differentiated CNE1 cells. As hypoxic exosomes enhanced the invasiveness and motility of normoxic NPC cells, hypoxia significantly increased the metastatic ability of CNE2 cells. Moreover, EMT occurred in hypoxic CNE2 cells regardless of cell morphology or the change of markers such as E-cadherin and Vimentin. Hypoxic CNE2 also showed increased metastatic ability compared to normal controls. Our data further demonstrated that hypoxic exosome-induced cell migration and invasion were dependent on MMP-13, which induced EMT of the recipient normoxic cell.
In conclusion, we provided evidence that hypoxia increased the MMP-13 levels in tumor-derived exosomes in a HIF-1α-dependent manner. Tumor-derived exosomes could function as a messenger that delivers MMP-13 between normoxic and hypoxic cancer cells and thus remodels the tumor microenvironment of NPC.
Materials and methods
Immunohistochemistry
All NPC specimens and normal nasopharyngeal epithelium samples were obtained from the Affiliated Hospital of Nantong University. No patients had received any anti-tumor treatments before biopsy. The procedure of human sample collection was approved by the Ethical Committee of the Affiliated Hospital of Nantong University. Informed consent was obtained from all patients.
Immunohistochemistry was used to analyze the expression of HIF-1α and MMP-13 in NPC. The procedure was as mentioned previously33. The slides were incubated with anti-human monoclonal antibody (Abcam, USA, 1:100), anti-human MMP-13 (Santa Cruz, CA, USA, 1:100). Briefly, according to the intensities of the nuclear, cytoplasm and/or membrane staining, staining intensity was scored as follows: 1, strong and moderate staining; 0, weak and no staining. Scores for the percentage of immunopositive cells were rated as follows: 0, <10% positive cells; 1, 10–25%; 2, 25–50%; and 3, >50% positive cells. Therefore, the combined staining scores (extent×intensity) could range from 0 to 3, and the cases were classified into negative group with scores ≦1 and positive group with scores >1.
Cell culture and treatment
Human NPC cell lines CNE1 and CNE2 were as gift from the Sun Yat-Sen University and Xiang-Ya School of Medicine, which were tested by the standard SRT method. They were cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco BRL, Grand Island, NY, USA). The cells were kept in a humidified atmosphere containing 5% CO2 and 21%O2. HUVECs were purchased from ScienCell Research Laboratories which were cultured in Dulbecco's modified Eagle's medium low glucose (HyClone, Logan, UT, USA).
Hypoxia treatment
Cells were incubated in a sealed incubator chamber that provided 1% O2, 5% CO2 and 94% N2 (Billups Rothenberg). Hypoxia was also induced by exposing cells to CoCl2 (Sigma‑Aldrich, St. Louis, MO, USA) in serum-free medium under normal conditions.
Exosome isolation and purification
Exosomes were isolated from CM as previously described18. The isolation method included a penultimate centrifugation step to remove small cell debris and then ultracentrifugation at 100,000 × g for 1 h to generate an exosome pellet (Type 90 Ti rotor; Beckman Coulter, Fullerton, CA). The pellets were then washed once with phosphate-buffered saline (PBS).
Electron microscopy
Purified exosome pellets were fixed with 2.5% glutaraldehyde and then centrifuged at 100,000 × g to remove the glutaraldehyde. The pellets were then negatively stained by 3% aqueous phosphotungstic acid and fixed on copper mesh formvar grids. Samples were observed using the JEOL Transmission Electron Microscope (JEM-1230; JEOL, Tokyo, Japan).
Western blot assay
Equal amounts of proteins were separated on 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis gel and transferred to polyvinylidene difluoride membranes. After blocking, the membrane was incubated with primary antibody against MMP-13, β-actin (Santa Cruz Biotechnology, CA, USA), HIF-1α (Abcam, USA), Vimentin, E-cadherin, Slug and Snail (Cell Signaling Technology, Danvers, MA, USA). Horseradish peroxidase (Santa Cruz Biotechnology, CA, USA)-conjugated secondary antibody was used and then visualized with ECL reagents.
Transwell migration and invasion assay
Migration
The 5 × 104 CNE2 or HUVECs were plated into the upper chambers of cell culture inserts (24-well type, 8 µm pore size, Millipore, MA), which were placed in medium containing 10% fetal bovine serum with or without exosomes. After 16 or 20 h of incubation at 37 °C, the chamber was washed and cells inside the upper chamber were removed. Cells on the lower membrane surface were fixed and stained with 0.25% crystal violet, and counted for 5 random per well. Cell counts are expressed as the mean number of cells per field of view.
Invasion
Transwell chambers were coated with Matrigel (BD, Bedford, MA, USA) and incubated. Cells (3 × 105) were plated into the top side of polycarbonate transwell filter and incubated for 24 h. Other processes were doing as migration.
Quantitative real-time PCR (qRT-PCR) analysis
Total RNA was extracted using Trizol® reagent (Invitrogen) from cells. The qRT-PCR was performed according to the instructions for Power SYBR Green PCR Master Mix (Applied Biosystems, USA). The cycle was 30 min at 42 °C, 2 min at 94 °C followed by 35 cycles of 94 °C for 20 s, one cycle of 58 °C for 20 s and elongation at 72 °C for 30 s. The sequences of the primers were as follows: MMP-13 (forward: GTGGTGGTGATGAAGATG; reverse: TCTAAGGTGTTATCGTCAAG); HIF-1α (forward: ACTCAGGACACAGATTTAGACTTG; reverse: TGGCATTAGCAGTAGGTTCTTG) E-cadherin (forward: GCTGGACCGAGAGAGTTTCC; reverse: CGACGTTAGCCTCGTTCTCA) Vimentin (forward: AAATGGCTCGTCACCTTCGT; reverse: CAGCTTCCTGTAGGTGGCAA) and GAPDH served as the internal control. The experiment was performed in triplicate.
siRNA transfection
The negative control siRNA (NC siRNA) and specific siRNAs were designed and obtained from Biomics Biotechnologies Co. Ltd (Nantong, China). HIF-1-α-targeted siRNA (sense, 5’-CGAUGGAAGCACUAGACAAdTdT-3’; antisense, 5’-UUGUCUAGUGCUUCCAUCGdTdT-3’) MMP-13-targeted siRNA (sense, 5’-GGAGAUAUGAUGAUACUAAdTdT-3’; antisense, 5’-UUAGUAUCAUCAUAUCUCCdTdT-3’) was chosen out of 4 individual siRNAs. Scrambled-sequence siRNA duplex was used as negative siRNA control.
Cell viability assay
Cells were seeded into 96-well plates and assessed by CCK8 assay (Beyotime Institute of Biotechnology, Haimen, China). The absorbance of each well was read on a microplate reader (F-2500 Fluorescence Spectrophotometer; Hitachi) at 450 nm.
Chromatin immunoprecipitation assay
ChIP assays were performed using a ChIP Assay Kit (Millipore) according to the manufacturer’s instructions. Briefly, cells were fixed, lysed and sonicated to obtain DNA fragments in arranging in size from 200 to1000 bp. Chromatin was then precipitated with nonspecific IgG antibodies (Millipore), anti-HIF-1α (Abcam). DNA was extracted and PCR was performed with primers for MMP-13 promoter fragment.
Lentivirus production and infection
Lentiviral particles carrying LV-MMP-13-shRNA vector and their flanking control sequence (Mock for short) were constructed by GeneChem (Shanghai, China). CNE2 cells were infected with lentiviral vector and the expression of MMP-13 was confirmed by western blot.
Animal xenograft tumor model
In vivo study was approved by the committee on the Ethics of Animal Experiments of Nantong University. All BALB/c at hymic nude mice (5 weeks old) were provided by Shanghai Laboratory Animal Center, China, and kept in a specific pathogen-free environment. All mouse experiments followed institutional guidelines. 1 × 106 CNE2 cells transfected with shMMP-13 and scramble shRNA or the control (N = 5 per group) in 0.1 ml 1640 medium without fetal bovine serum were subcutaneously injected into the mice. Tumors were allowed to grow for 3 days and then injected 20 μg of total exosome protein (in a total volume of 100 μl of PBS) three times a week, and PBS was used as control. Tumors were measured with sliding calipers and volume was calculated as (length×width2)/2. After 27 days, the mice were killed and tumor tissues were fixed in 10% formalin overnight or kept at –80 °C for later research.
Zebrafish tumor model
The development of zebrafish tumor model followed institutional guidelines21. Briefly, fertilized zebrafish eggs of the transgenic zebrafish Tg (fli1a: GFP) were incubated at 28 °C in an incubator. To prevent pigmentation, embryos at 22 h post fertilization (hpf) were treated with 0.2 mM 1-phenyl-2-thiourea. At 48 hpf, anesthetized zebrafish embryos were placed onto a modified agarose gel for microinjection. Before injection, 2 g/ml of DiI (Fluka, Germany) was used to label tumor cells in vitro. Approximately 100–500/5 nl tumor cells were resuspended in serum-free 1640 medium and then injected into the perivitelline cavity of each embryo using a microinjection system (WPI).
Immunocytochemical analysis
Cells were grown on glass cover slips, washed and fixed with 4% paraformaldehyde. The cover slips were then incubated with 1% bovine serum albumin in PBS and with primary antibody overnight, washed and incubated with fluorescein isothiocyanate-labeled secondary antibodies (Earth Ox) and the nuclei were labeled with Hoechst (Invitrogen) for 1 h. The cover slips were then observed under an Olympus camera.
Transmission electron microscopy
According to the manufacturer’s instructions, PKH67 (Sigma-Aldrich)-labeled exosomes were added to CNE2 cells. The cells were fixed and then processed as introduced immunocytochemical analysis. Images were collected with a TCS SP5 confocal microscope (Leica Microsystems, Wetzlar, Germany) as mentioned previously18.
Statistical analysis
Each experiment was performed as least three times; data were presented as mean ± SEM. Statistical analyses were performed using SPSS17.0 software. A value of P < 0.05 was considered statistically significant. Survival curves were estimated by Kaplan–Meier analysis and compared by the log-rank test. χ2 test was used to determine the significance of differences in multiple comparisons.
References
Chua, M. L. Gemcitabine: a game changer in nasopharyngeal carcinoma. Lancet 388, 1853–1854 (2016).
Chua, M. L., Wee, J. T. & Hui, E. P. Nasopharyngeal carcinoma. Lancet 387, 1012–1024 (2016).
Li, X. J. et al. As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signaling. Carcinogenesis 22, 1302–1309 (2012).
Pan, W. L. et al. Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. Biochem. Pharmacol. 89, 329–339 (2014).
Kucharzewska, P. et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA 110, 7312–7317 (2013).
Bao, B. et al. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim. Biophys. Acta 1826, 272–296 (2012).
King, H. W., Michael, M. Z. & Gleadle, J. M. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12, 421–430 (2012).
Liang, X. H. et al. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral. Oncol. 47, 92–97 (2011).
Shan, Y. et al. MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma. Oncol. Rep. 34, 1943–1952 (2015).
Masoud, G. N. & Li, W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm. Sin. B 5, 378–389 (2015).
Choi, J. Y., Jang, Y. S. & Min, S. Y. Overexpression of MMP-9 and HIF-1α in breast cancer cells under hypoxic conditions. J. Breast Cancer 14, 88–95 (2011).
Lee, Y. A. et al. Hypoxia differentially affects IL-1 beta-stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1 alpha-dependent manner. Rheumatology 51, 443–450 (2012).
Koong, A. C. et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60, 883–887 (2000).
Luukkaa, M. et al. Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 28, 225–234 (2006).
Elnemr, A. et al. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 6, 30–38 (2003).
Nielsen, B. S. et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res. 61, 7091–7100 (2001).
Palkina, N. V., Shvetsova, Y. I. & Kirichenko, A. K. Inhibition of matrix metalloproteinases 9 and 13 affects the degree of lymphocytic infiltration and the expression levels of microRNA miR-21 and miR-let-7b in melanoma cells in vivo. Arkh Patol. 77, 41–47 (2015).
You, Y. et al. Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis. Cancer Sci. 106, 1669–1677 (2015).
Shenoy, G. N. et al. Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T cell responses. Cancer Immunol. Res. 6, 236–247 (2018).
Hsu, Y. L. et al. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene 36, 4929–4942 (2017).
Lee, S. L. C. et al. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc. Natl. Acad. Sci. USA 106, 19485–19490 (2009).
Nicoli, S. & Presta, M. The zebrafish/tumor xenograft angiogenesis assay. Nat. Protoc. 2, 2918–2923 (2007).
Chen, Y. et al. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosis. Med. Oncol. 31, 304–311 (2014).
Liu, Z. et al. Hypoxia accelerates aggressiveness of hepatocellular carcinoma cells involving oxidative stress, epithelial-mesenchymal transition and non-canonical Hedgehog signaling. Cell Physiol. Biochem. 44, 1856–1868 (2017).
Umezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K. & Ohyashiki, JH. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 124, 3748–3757 (2014).
Tadokoro, H. et al. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J. Biol. Chem. 288, 34343–34351 (2013).
Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastas. Rev. 26, 225–239 (2007).
Schofield, C. J. & Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343–354 (2004).
Choi, J. Y., Jang, Y. S., Min, S. Y. & Song, J. Y. Overexpression of MMP-9 and HIF-1 alpha in breast cancer cells under hypoxic conditions. J. Breast Cancer 14, 88–95 (2011).
Li, L. et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 76, 1770–1780 (2016).
Kashiwagi, S. et al. Mesenchymal-epithelial transition and tumor vascular remodeling in eribulin chemotherapy for breast cancer. Anticancer Res. 38, 401–410 (2018).
Zhang, L. et al. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1 alpha in hepatocellular carcinoma. BMC Cancer 13, 108–117 (2013).
Bao, L. et al. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. Biochem. Biophys. Res. Commun. 476, 467–474 (2016).
Acknowledgements
This study was supported by grants from the Chinese National Natural Science Foundation (Grant Nos. 81672682 and 81602385) and the Natural Science Foundation of Jiangsu Province (Grant No. SBK20151266).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shan, Y., You, B., Shi, S. et al. Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases. Cell Death Dis 9, 382 (2018). https://doi.org/10.1038/s41419-018-0425-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-018-0425-0
This article is cited by
-
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Journal of Biomedical Science (2024)
-
Hypoxic regulation of ADAMTS-2 and -3 (a disintegrin and matrix metalloproteinase with thrombospondin motifs 2 and 3) procollagen N proteinases by HIF-1α in endothelial cells
Molecular and Cellular Biochemistry (2023)
-
The impact of hypoxia on extracellular vesicle secretome profile of cancer
Medical Oncology (2023)
-
Tridimensional cell culture of dermal fibroblasts promotes exosome-mediated secretion of extracellular matrix proteins
Scientific Reports (2022)
-
Exosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer
3 Biotech (2022)